Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies

Autoimmune hepatitis (AIH) is a severe liver disease that arises in genetically predisposed male and female individuals worldwide. Diagnosis of AIH is made clinically applying diagnostic scores; however, the heterotopic disease phenotype often makes a rapid determination of disease challenging. AIH...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2019/9437043
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564758084059136
author Elisabeth Sucher
Robert Sucher
Tanja Gradistanac
Gerald Brandacher
Stefan Schneeberger
Thomas Berg
author_facet Elisabeth Sucher
Robert Sucher
Tanja Gradistanac
Gerald Brandacher
Stefan Schneeberger
Thomas Berg
author_sort Elisabeth Sucher
collection DOAJ
description Autoimmune hepatitis (AIH) is a severe liver disease that arises in genetically predisposed male and female individuals worldwide. Diagnosis of AIH is made clinically applying diagnostic scores; however, the heterotopic disease phenotype often makes a rapid determination of disease challenging. AIH responds favorably to steroids and pharmacologic immunosuppression, and liver transplantation is only necessary in cases with acute liver failure or end-stage liver cirrhosis. Recurrence or development of de novo AIH after transplantation is possible, and treatment is similar to standard AIH therapy. Current experimental investigations of T cell-mediated autoimmune pathways and analysis of changes within the intestinal microbiome might advance our knowledge on the pathogenesis of AIH and trigger a spark of hope for novel therapeutic strategies.
format Article
id doaj-art-7583b5799ec644b0ab0460f6ead5a926
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-7583b5799ec644b0ab0460f6ead5a9262025-02-03T01:10:21ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/94370439437043Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic StrategiesElisabeth Sucher0Robert Sucher1Tanja Gradistanac2Gerald Brandacher3Stefan Schneeberger4Thomas Berg5Division of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectiology, and Pneumology, University Clinic Leipzig, GermanyDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, Division of Hepatobiliary Surgery and Visceral Transplant Surgery, University Clinic Leipzig, GermanyDepartment of Pathology, University Clinic Leipzig, GermanyDepartment of Plastic and Reconstructive Surgery, Vascularized Composite Allotransplantation (VCA) Laboratory, Johns Hopkins University, Baltimore, Maryland, USADepartment of Visceral, Transplant, and Thoracic Surgery, University Clinic Innsbruck, Tirol, AustriaDivision of Hepatology, Clinic and Polyclinic for Gastroenterology, Hepatology, Infectiology, and Pneumology, University Clinic Leipzig, GermanyAutoimmune hepatitis (AIH) is a severe liver disease that arises in genetically predisposed male and female individuals worldwide. Diagnosis of AIH is made clinically applying diagnostic scores; however, the heterotopic disease phenotype often makes a rapid determination of disease challenging. AIH responds favorably to steroids and pharmacologic immunosuppression, and liver transplantation is only necessary in cases with acute liver failure or end-stage liver cirrhosis. Recurrence or development of de novo AIH after transplantation is possible, and treatment is similar to standard AIH therapy. Current experimental investigations of T cell-mediated autoimmune pathways and analysis of changes within the intestinal microbiome might advance our knowledge on the pathogenesis of AIH and trigger a spark of hope for novel therapeutic strategies.http://dx.doi.org/10.1155/2019/9437043
spellingShingle Elisabeth Sucher
Robert Sucher
Tanja Gradistanac
Gerald Brandacher
Stefan Schneeberger
Thomas Berg
Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
Journal of Immunology Research
title Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
title_full Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
title_fullStr Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
title_full_unstemmed Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
title_short Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies
title_sort autoimmune hepatitis immunologically triggered liver pathogenesis diagnostic and therapeutic strategies
url http://dx.doi.org/10.1155/2019/9437043
work_keys_str_mv AT elisabethsucher autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies
AT robertsucher autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies
AT tanjagradistanac autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies
AT geraldbrandacher autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies
AT stefanschneeberger autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies
AT thomasberg autoimmunehepatitisimmunologicallytriggeredliverpathogenesisdiagnosticandtherapeuticstrategies